Table 1.
Clinical and pathological characteristics of the HCC patients retrieved from the TCGA and ICGC databases.
| Characteristics | TCGA Cohort | ICGC LIRI-JP Cohort | |
|---|---|---|---|
| Total number of patients | 365 | 231 | |
| Survival status | Survival | 235 (64.38%) | 189 (81.82%) |
| Death | 130 (35.62%) | 42 (18.18%) | |
| Age | ≤65 years | 227 (62.19%) | 89 (38.53%) |
| >65 years | 138 (37.81%) | 142 (61.47%) | |
| Sex | Male | 246 (67.40%) | 170 (73.59%) |
| Female | 119 (32.60%) | 61 (26.41%) | |
| Stage | I | 170 (46.58%) | 36 (15.58%) |
| II | 84 (23.01%) | 105 (45.45%) | |
| III | 83 (22.74%) | 71 (30.74%) | |
| IV | 4 (1.10%) | 19 (8.23%) | |
| Unknow | 24 (6.57%) | 0 | |
| Pathological grade (Edmondson) | G1 | 55 (15.07%) | 20 (8.66%) |
| G2 | 175 (47.94%) | 134 (58.01%) | |
| G3 | 118 (32.33%) | 56 (24.24%) | |
| G4 | 12 (3.29%) | 1 (0.43%) | |
| Unknow | 5 (1.37%) | 20 (8.66%) | |
| Metastasis | Primary HCC | 365 | 201 (87.01%) |
| Metastatic HCC | 0 | 30 (12.99%) |